Periodontal Health
Company announces additional results in phase I dental study
Published in Gene Therapy Weekly, March 25th, 2004
Isolagen, Inc., (ILE), a biopharmaceutical company specializing in the development and commercialization of autologous cellular therapy for hard and soft tissue regeneration ("the Isolagen Process"), announced additional findings from further analysis of results from a 6-month, double-blind clinical study in which their proprietary treatment successfully reversed gingival recession and improved deep-periodontal pocketing.
The clinical examinations of 176 intra-oral sites in 21 subjects were conducted at the University of Texas Health Science Center Dental Branch and represent the company's first set of clinical data in the oral healthcare market.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-03-25)
More Articles from Gene Therapy Weekly
- Gene Transfer
Retroviral constructs directed against CEA foster tumor cell transduction - Oncology
Apoptin expression kills human biliary tract cancer cells - Gene Delivery
Calfection gives scientists a way to transfect cells in suspension cultures - Genetic Engineering
DNA from modified plants are not transferred to the gastrointestinal tract - Neuroscience
Pseudotyped lentiviral vectors provide strong nervous system transduction - Transplant Medicine
Gene therapy protects livers from transplant-related injury - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
